Siegfried Kasper

45PUBLICATIONS
118CO-AUTHORS
Epidemiological methodsPharmacogenomicsPharmaceutical delivery technologiesClinical pharmacology and therapeuticsPersonality and individual differences
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jun 23, 2026
Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry.

|Jun 07, 2026
Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program.

|Apr 29, 2026
Pharmacological augmentation in treatment-resistant depression: a neurobiologically informed, practical decision guide for treatment choice with lithium, quetiapine, or esketamine.

|Mar 25, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.

Joseph F Goldberg, Holly A Swartz, Roger S McIntyre

|Feb 06, 2026
Expert consensus on the use of trazodone in patients with major depressive disorder: results from a European Delphi panel.

Allan Hunter Young, Andrea Fagiolini, Luis Agüera-Ortiz

|Jan 08, 2026
Neuropsychiatric manifestations of primary hyperparathyroidism.

Marco Mairinger, Godber Mathis Godbersen, Siegfried Kasper

Pageof 8

Frequent Collaborators

10 joint publications

Markus Dold

10 joint publications

Lucie Bartova

9 joint publications

Alessandro Serretti

7 joint publications

Alexander Kautzky